We comprehensively evaluated the correlation between RDM1 expression and patient prognosis as well as the expression of tumor infiltrating immune cells in different types of tumor tissues, including liver cancer, through the use of PrognoScan, Kaplan–Meier plotter, Gene Expression Analysis Interactive Analysis (GEPIA) and TIMER. The gene discussed is RDM1; the disease is liver cancer.